Lucy Bataneant is listed as an executive officer on 2 SEC Form D filings by 1 issuer between May 2025 and Nov 2025: ABK Biomedical Inc (Halifax, Nova Scotia, Canada (as filed: A5) — industry reported as "Other" — 2025; $28.5M reported sold to 24 investors).
What this means One deal on file with the SEC, filed Nov 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Lucy Bataneant and found 1 difference: Form D filed 20 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.